This page follows insider dealings at Primo Nutraceuticals Inc. as filed with SEDI. Nothing new has been filed by managers of Primo Nutraceuticals Inc. in twelve months, the latest record being from 23 November 2020.
Looking back to 2019, when coverage begins, insiders filed 3 purchases and 14 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 36 declarations
Primo Nutraceuticals Inc. is a company focused on the development and marketing of nutraceutical products. It is listed on the Toronto Stock Exchange (XTSE).